First Fibroblast Injection Performed in SpinalCyte's Landmark Trial for Spinal Disc Regeneration
SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on the regrowth of the spinal disc nucleus using human dermal fibroblasts, announced the first injection of fibroblasts for the regeneration of the spinal disc.